Table 6 Distribution of VAV2 rs602990 genotypes among male patients with and without target organ damage.
From: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
SNP | Genotype | Target organ damage | P value | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
Yes | No | ||||||
N | % | N | % | ||||
VAV2 rs602990 | CC | 19 | 17.8 | 31 | 33.3 | Ref. | 1.000 |
CT | 63 | 58.9 | 40 | 43.0 | 0.026 | 2.253 (1.101–4.613) | |
TT | 25 | 23.4 | 22 | 23.7 | 0.298 | 1.559 (0.675–3.598) | |
VAV2 rs602990 dominant | CC | 19 | 17.8 | 31 | 33.3 | Ref. | 1.000 |
CT + TT | 88 | 82.2 | 62 | 66.7 | 0.044 | 2.007 (1.018–3.956) | |
VAV2 rs602990 recessive | CC + CT | 82 | 76.6 | 71 | 76.3 | Ref. | 1.000 |
TT | 25 | 23.4 | 22 | 23.7 | 0.746 | 0.894 (0.454–1.760) | |
